Infant botulism is a paralytic syndrome which manifests as a result of ingesting spores of the toxin secreting bacterium Clostridium botulinum by infants. As opposed to botulism in adults, treating infant botulism with horse antiserum was not approved due to several safety issues. This restriction has led to the development of Human Botulism Immune Globulin Intravenous (BIG-IV; sells under BabyBIG). In this article we review infant botulism and the advantages of treating it with BIG-IV.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
infant botulism
12
botulism
5
[infant botulism]
4
botulism] infant
4
botulism paralytic
4
paralytic syndrome
4
syndrome manifests
4
manifests result
4
result ingesting
4
ingesting spores
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!